Iron chelator CP94 enhances nodular BCC response to PDT


Washington - Enhanced 5-aminolevulinic acid photodynamic therapy (ALA PDT) performed with use of the novel iron chelator CP94 shows promise for improving the efficacy of topical PDT for nodular basal cell carcinoma (BCC), said Colin A. Morton, M.D., at the annual meeting of the American Academy of Dermatology.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.